Company Snapshot: OSTE  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule

    EATONTOWN, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE) announced today that the Company's third quarter ended
September 30, 2008 financial results will be released Friday, November 7,
2008. A conference call will be conducted by Sam Owusu-Akyaw, President and
Chief Executive Officer, as well as other members of Osteotech management,
on Friday, November 7, 2008, at 9:00 a.m. Eastern time. You are invited to
listen to the conference call by dialing 1-973-200-3375. Automated playback
will be available two hours after completion of the live call through
midnight, Friday, November 21, 2008 by dialing 1-706-645-9291 and
indicating access code 66480835.

    A live, listen-only webcast of our conference call will also be
available at our investor site at http://www.osteotech.com on the Financial
Highlights page. A replay of the conference call and the question/answer
session will be available at the Company's website for approximately 14
days following the call. It will be necessary to have RealPlayer installed
on your computer.

    Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global
leader in providing OsteoBiologic solutions for regenerative medicine to
support surgeons and their patients in the repair of the musculoskeletal
system through the development of innovative therapy-driven products that
alleviate pain, promote biologic healing and restore function. For further
information regarding Osteotech, this press release or the conference call,
please go to Osteotech's website at http://www.osteotech.com.



SOURCE Osteotech, Inc.




Back to Topback to top

Related links:
  • http://www.osteotech.com
  • http://www.prnewswire.com/comp/668050.html /
    CONTACT:
    Mark H. Burroughs, +1-732-542-2800